Scarica l'app Stockscreener
6.60
2.00%
-0.135
Dopo l'orario di chiusura:
6.65
0.05
+0.76%
Precedente Chiudi:
$6.735
Aprire:
$6.71
Volume 24 ore:
49,842
Relative Volume:
0.33
Capitalizzazione di mercato:
$57.23M
Reddito:
$137.27M
Utile/perdita netta:
$-123.57M
Rapporto P/E:
-0.6027
EPS:
-10.95
Flusso di cassa netto:
$-102.89M
1 W Prestazione:
-7.17%
1M Prestazione:
+70.10%
6M Prestazione:
+7.84%
1 anno Prestazione:
-44.84%
Intervallo 1D:
$6.59
$7.00
Intervallo di 1 settimana:
$6.59
$7.22
Portata 52W:
$3.51
$16.95
Karyopharm Therapeutics Inc Stock (KPTI) Company Profile
Nome
Karyopharm Therapeutics Inc
Settore
Industria
Telefono
617-658-0600
Indirizzo
85 WELLS AVENUE, NEWTON, MA
Confronta KPTI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KPTI
Karyopharm Therapeutics Inc
|
6.60 | 58.40M | 137.27M | -123.57M | -102.89M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-07-11 | Ripresa | H.C. Wainwright | Buy |
| 2023-01-19 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-09 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-11-19 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-08-06 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-08-06 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-07-02 | Iniziato | Morgan Stanley | Overweight |
| 2020-03-04 | Iniziato | Barclays | Overweight |
| 2020-01-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-07-23 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-07-05 | Reiterato | H.C. Wainwright | Buy |
| 2019-07-05 | Reiterato | Robert W. Baird | Outperform |
| 2019-03-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-02-28 | Reiterato | BofA/Merrill | Underperform |
| 2019-02-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-01-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2018-12-03 | Iniziato | B. Riley FBR | Buy |
| 2018-11-09 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2018-05-24 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-04-02 | Ripresa | Leerink Partners | Outperform |
| 2017-11-15 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2016-09-08 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-08-18 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-28 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie
Is Karyopharm Therapeutics Inc. gaining market share2025 Earnings Surprises & Technical Analysis for Trade Confirmation - classian.co.kr
Analyzing recovery setups for Karyopharm Therapeutics Inc. investorsJuly 2025 Rallies & Verified Momentum Stock Ideas - Newser
Multi factor analysis applied to Karyopharm Therapeutics Inc.2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
Will Karyopharm Therapeutics Inc. benefit from current market trendsMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Can Karyopharm Therapeutics Inc. recover in the next quarterJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Is Karyopharm Therapeutics Inc. benefiting from innovation trendsJuly 2025 Trends & Free Community Supported Trade Ideas - خودرو بانک
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Karyopharm Therapeutics Inc. stock daily chart insights2025 Retail Activity & Low Drawdown Trading Techniques - Newser
What are Karyopharm Therapeutics Inc.’s recent SEC filings showingWeekly Profit Summary & AI Based Buy and Sell Signals - خودرو بانک
Is Karyopharm Therapeutics Inc. trending in predictive chart modelsMarket Risk Report & Fast Moving Stock Watchlists - Newser
What candlestick patterns are forming on Karyopharm Therapeutics Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Using data tools to time your Karyopharm Therapeutics Inc. exitJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Is Karyopharm Therapeutics Inc. in a long term uptrendTrade Exit Report & Real-Time Volume Surge Alerts - خودرو بانک
Strategies to average down on Karyopharm Therapeutics Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - Newser
Published on: 2025-09-04 06:44:04 - Newser
Published on: 2025-09-04 06:43:46 - Newser
Can Karyopharm Therapeutics Inc. hit a new high this month2025 Bull vs Bear & Stock Market Timing Techniques - Newser
Automated trading signals detected on Karyopharm Therapeutics Inc.2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
Will Karyopharm Therapeutics Inc. benefit from rate cutsJuly 2025 News Drivers & Comprehensive Market Scan Reports - خودرو بانک
What machine learning models say about Karyopharm Therapeutics Inc.Trade Exit Summary & Weekly High Potential Alerts - Newser
Is now the right time to enter Karyopharm Therapeutics Inc.Weekly Risk Report & Fast Gain Swing Alerts - خودرو بانک
How to use a screener to detect Karyopharm Therapeutics Inc. breakoutsStock Surge & Free Technical Confirmation Trade Alerts - Newser
Karyopharm Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
What high frequency data says about Karyopharm Therapeutics Inc.Weekly Stock Recap & Accurate Entry/Exit Alerts - Newser
Can you recover from losses in Karyopharm Therapeutics Inc.July 2025 EndofMonth & Accurate Entry/Exit Alerts - Newser
Analyzing Karyopharm Therapeutics Inc. with multi timeframe chartsQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
How Karyopharm Therapeutics Inc. stock reacts to Fed policy changesBull Run & Real-Time Volume Spike Alerts - Newser
Published on: 2025-09-01 11:39:57 - beatles.ru
What momentum shifts mean for Karyopharm Therapeutics Inc.2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
Forecasting Karyopharm Therapeutics Inc. price range with options dataMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
How to read the order book for Karyopharm Therapeutics Inc.Market Sentiment Report & Reliable Price Action Trade Plans - Newser
Will Karyopharm Therapeutics Inc. stock go up soon2025 Risk Factors & Low Risk High Reward Ideas - Newser
Trend analysis for Karyopharm Therapeutics Inc. this weekJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Using AI based signals to follow Karyopharm Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - Newser
Karyopharm Therapeutics Inc Azioni (KPTI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):